» Articles » PMID: 15741621

Ibandronate for Prevention of Femoral Head Deformity After Ischemic Necrosis of the Capital Femoral Epiphysis in Immature Pigs

Overview
Date 2005 Mar 3
PMID 15741621
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Femoral head deformity is the most serious sequela of ischemic necrosis of the immature femoral head. The purpose of this study was to determine if a highly potent antiresorptive agent, ibandronate, can inhibit bone resorption during the repair of the infarcted femoral head and thus alter the repair process. We hypothesized that preservation of the trabecular framework by inhibiting osteoclastic bone resorption would minimize the development of deformity in a piglet model of ischemic necrosis. The effect of ibandronate on long-bone growth was also assessed.

Methods: Ischemic necrosis of the right femoral head was produced in twenty-four piglets by placing a ligature tightly around the femoral neck. The animals were divided into three groups according to whether they received saline solution, prophylactic treatment, or post-ischemia treatment. The contralateral, untreated femoral heads from the animals that had received saline solution served as the normal control group. At eight weeks, the femoral heads were assessed for deformity with radiography and for trabecular bone indices with histomorphometry. Also, the length of femur from the untreated side was measured on the radiographs and compared among the groups.

Results: Radiographic assessment showed that the epiphyseal quotient, determined by dividing the maximum height of the osseous epiphysis by the maximum diameter, was better preserved in the prophylactic (p < 0.001) and post-ischemia (p = 0.02) treatment groups than in the group treated with saline solution. Histomorphometric assessment also showed that the trabecular bone indices were better preserved in the prophylactic and the post-ischemia treatment groups than in the group treated with saline solution (p < 0.01). The mean femoral length on the untreated side of the animals treated with ibandronate was reduced compared with the length on the untreated side of the animals that had received saline solution (p </= 0.01).

Conclusions: Ibandronate preserves the trabecular structure of the osseous epiphysis and prevents femoral head deformity during the early phase of repair of ischemic necrosis in the piglet model.

Citing Articles

Progress in understanding Legg-Calvé-Perthes disease etiology from a molecular and cellular biology perspective.

Zheng X, Dong Z, Ding X, Huang Q, Tang S, Zhang Y Front Physiol. 2025; 16:1514302.

PMID: 40041162 PMC: 11876877. DOI: 10.3389/fphys.2025.1514302.


Biochanin A inhibits endothelial dysfunction induced by IL‑6‑stimulated endothelial microparticles in Perthes disease via the NFκB pathway.

Liu J, Lin C, Li B, Huang Q, Chen X, Tang S Exp Ther Med. 2024; 27(4):137.

PMID: 38476892 PMC: 10928846. DOI: 10.3892/etm.2024.12425.


Animal Model Standardization for Studying Avascular Necrosis of the Femoral Head in Legg-Calvé-Perthes Disease.

Miashiro E, Zanella L, Cardoso G, Silva G, de Angelis K, de Almeida S Rev Bras Ortop (Sao Paulo). 2023; 58(5):e771-e780.

PMID: 37908528 PMC: 10615593. DOI: 10.1055/s-0042-1749418.


Dragon blood resin ameliorates steroid-induced osteonecrosis of femoral head through osteoclastic pathways.

Liu Y, Mo L, Lu H, Wei Y, Zhang J, Bennett S Front Cell Dev Biol. 2023; 11:1202888.

PMID: 37675145 PMC: 10477996. DOI: 10.3389/fcell.2023.1202888.


Interleukin-6 receptor blockade improves bone healing following ischemic osteonecrosis in adolescent mice.

Kuroyanagi G, Kamiya N, Yamaguchi R, Kim H Osteoarthr Cartil Open. 2023; 5(4):100386.

PMID: 37600923 PMC: 10432805. DOI: 10.1016/j.ocarto.2023.100386.